SUMMARY The hypothesis that the presence of glycochenodeoxycholic acid (GCDC) in the human lleal bile acid concentrations showed a 54-0 (9.3) % absorption of glycochenodeoxycholic acid by the been tested in healthy volunteers. Mean transit times, flow rates and intraluminal pressures in a 40 cm jejunal segment proximal (n=6) and a 40 cm ileal segment distal (n=6) to a GCDC infusion port were measured. During GCDC infusion (60 pimoVmin) jejunal and ileal transit were markedly (p<005) delayed (31.6 (7.7), mean (SEM) v 14.5 (3.8) min and 37.0 (5.7) v 21-0 (3.5) min, respectively), segment volumes increased (141.1 (30.2) v 59.2 (9.9) ml and 173.2 (26.3) v 83.9 (9.5) ml; p<0 05), while flow rates did not change significantly (4.6 (0.6) v 4.5 (0.6) mImin and 4-8 (0.5) v 4.2 (0.3) mUmin, respectively). Ileal pressures (distal to the GCDC infusion port) decreased (p<005) promptly (1.0 (0.1) min) after the start of GCDC infusion. Inhibition of jejunal motility was more gradual and reached significance (p<005) only 30 min after beginning of the infusion. Ileal bile acid concentrations showed a 54-0 (9.3)% absorption of glycochenodeoxycholic acid by the 40 cm ileal segment. These observations suggest the existence of an intestinal control mechanism in healthy man, whereby presence of glycochenodeoxycholic acid in the ileum inhibits motility and delays transit in the jejunum and ileum.
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We have previously shown' that jejunal infusion of glycochenodeoxycholic acid prolonged jejunocaecal transit time and decreased jejunal motility. The inhibition of motility was delayed with respect to the start of the infusion, suggesting the posibility that the inhibitory effect could originate in the distal instestine. The ileum is known to be the site of a regulatory mechanism involving fat,23 likely to maximise absorption and prevent escape into the caecum of diarrhoeogenic compounds.4 In previous perfusion studies, chenodeoxycholic acid was found to inhibit water and electrolyte absorption from the human ileum.5 A short segment, however, was studied at high infusion rate and an occlusive balloon was used, which is known to inhibit motility distal to it. 6 The present study was designed to investigate whether ileal infusion of glycochenodeoxycholic acid (GCDC) had an effect on fed motility, transit time, and flow rate in the human jejunum and ileum.
Methods

SUBJECTS
Two sets of experiments on healthy adult volunteers were carried out. The first set (numbered [1] [2] [3] [4] [5] [6] investigated the effect of ileal infusion of GCDC on the jejunum and the second set (numbered [7] [8] [9] [10] [11] [12] investigated the effect on the ileum.
Ten healthy subjects (aged [21] [22] [23] [24] [25] [26] Each study comprised an equilibration period (one hour), a control period (two hours), and a GCDC period (two hours). After the tube had reached its position (median 4-5 h, range 3-5-5-5 h), jejunal perfusion was started through J at 4 mImin with a solution containing starch hydrolysate (Polycal, Nutricia; 2 kcal/min) and through P at 1 ml/min with saline containing ['4C]PEG and was continued throughout the study. Starch hydrolysate was added to the jejunal infusate to induce and maintain a fed pattern of motility. One hour into the control and GCDC periods a bolus of bromosulphthalein (BSP, 50 mg) was injected rapidly through J for the measurement of jejunal transit.
During the first 80 minutes of control and GCDC periods the ileum was perfused through I at 2 ml/min with saline and a solution containing GCDC, total dose 5 mmol (concentration 30 mmol/l), respectively. The composition of all test solutions is shown in Table 1 .
Aspiration of jejunal fluid was done throughout the study through port A with the help of an air bleed. The aspirate obtained during the first hour of control and GCDC periods was discarded, while in the second hour of both periods 2 Experiments 7-12 ( Fig. 2b ) Each study comprised an equilibration period (one hour), a control period (two hours), and a GCDC period (two and a half hours). After the tube had reached its position (median 5 hours, range 3 to 6 hours), the jejunum was perfused through J at 2 ml/ min with a solution containing starch hydrolysate (2 kcalUmin) throughout the experiment to maintain the fed pattern of motility. The ileum was perfused through port I at 4 mLimin with saline, except for the first 80 minutes of the GCDC period, when perfusion was done with a solution containing GCDC, total dose 5 mmol (concentration 15 mmol/l). ['4C]PEG in saline was perfused through P at 1 mllmin throughout the experiment. One hour into control and GCDC period a bolus of BSP (50 mg) was injected through port I for the measurement of ileal transit. The composition of the test solutions is shown in Table 1 .
Aspiration of ileal fluid was done throughout the study through port A with the help of an air bleed: during the second hour of control and GCDC periods, samples (2 ml) were collected every two minutes for analysis of [4C)PEG, BSP, and bile acids.
In all experiments (1-12), to provide adequate flow for aspiration, lactulose ( 
Experiments 1-6
Percentage duration of pressure activity decreased markedly in the tracings recorded through i2 and i3 (distal to the I infusion port), after the start of the GCDC infusion (Figs 4-5) . Inhibition began 1.5 (0.2) minutes (i2 port) and 2.4 (0.5) minutes (i3 port) after the start of the GCDC infusion and lasted for the whole two hours of the test period. During the first 30 minutes of GCDC infusion isolated high amplitude (50-115 mmHg) waves of long duration (15-30 sec) were present in two subjects: one subject had three, one of which seemed to propagate rapidly from i2 to i3 (20 cm/min), the other subject had one in i2 and one in i3, respectively. Proximal to the GCDC infusion port, inhibition in the ileum (il) and in the jejunum (i1, j2, j3) was less marked and started gradually, reaching significance only during the second 30 minutes of GCDC infusion.
Experiments [7] [8] [9] [10] [11] [12] Percentage duration of pressure activity decreased (Figs 6 and 7 ) in all the 40 cm of ileum during infusion of GCDC. The inhibition was immediate at the proximal port il, starting 1*0 (0.1) minute after the (Fig. 6) .
During GCDC infusion isolated prolonged (12-18 sec), high amplitude (50-105 mmHg) waves were recorded (Fig. 8 ) in three subjects: in one subject the three waves were present in one port (il, i2, i4) at a time; in a second subject two prolonged contractions propagated (70-90 cm/min) along the four proximal ports. The third subject had four prolonged contractions (all in the first 30 minute period of GCDC infusion) propagated (35-90 cm/min) along two to four ports. There were no subjective symptoms coinciding with the high amplitude waves. (Table 3) were , o 9 *,f similar during control and GCDC periods in experiments 1-6. In experiments 7-12 bile acid concentra-* tions increased significantly (p<0-05) during GCDC infusion and showed absorption of some of the GCDC infusion infused bile acid. Considering that GCDC was 0°infused at 60 itmol/min and that at the aspiration site 
SIDE EFFECTS
In experiments 1-6 one subject experienced central abdominal discomfort lasting for one hour during GCDC infusion. His motility record was similar to the other symptom free subjects.
Discussion
This study showed that when GCDC, one of the two predominant primary bile acids in man," was infused into the ileum an inhibition of motility at sites in the jejunum and the ileum was triggered. As a result of the inhibition, no increase was observed in ileal flow during GCDC infusion despite its secretory action.5 Intraluminal pressure responses distal and proximal to the GCDC infusion site appear to be different. Distal to the infusion port (experiments 1-6 and 7-12) inhibition of pressure activity was almost immediate at the more proximal ports and progressively delayed at the ports more distal from the infusion site. These data suggest that the inhibitory effect was mediated by direct contact between GCDC and mucosal chemoreceptors sensitive to the bile acid. Furthermore this pattern of response seems to be site-specific for the ileum, because perfusing the jejunum with the same infusate triggers a delayed, more gradual inhibition of jejunal motility. ' Proximal to the infusion port (experiments 1-6), inhibitory response was slower to start and more gradual. In addition, proximal inhibition of pressure activity did not appear to need intraluminal presence of the bile acid, as the jejunal concentration of bile acids remained in the fasting range during the GCDC period (Table 3) ,12 suggesting that the infused GCDC, at least partly absorbed by the ileum during the experiment, did not circulate significantly from the liver back into the small intestine. As distention of an intestinal segment is known to produce inhibition of motility in the remainder of the intestine,'3 1 ' it is possible that distention of the ileum distal to the GCDC infusion port (Table 2) caused by the motor and secretory effects of the bile acid was the determinant of inhibition of motility in the proximal intestine. The ileal inhibitory reflex provoked by fat, which has been characterised recently,' is likely to be operating in patients with steatorrhoea, but its presence in healthy people is still uncertain. By contrast, the inhibitory reflex described in this paper may be present after meals in healthy people, as infusion rates and concentrations of GCDC mimicked the postprandial secretion rates and intestinal concentrations of endogenous bile acids in healthy subjects.'" " Although an additional bile acid pool in the form of GCDC was given to our volunteers, our experimental model allowed us to study the fed state without stimulation of endogenous bile acid secretion, thus excluding the endogenous pool and an unphysiological overload of bile acids to the small intestine. During jejunal infusion of starch hydrolysate small bowel motility was in the fed state and intestinal concentrations of bile acids (when corrected for the infusion rate) were in the fasting range" throughout the studies, except in the ileum at the time of GCDC infusion. Bile acids are necessary for absorption of fat'" and they are actively absorbed in the distal small bowel. 7'" Therefore, although caution should be observed in extrapolating experimental findings to the real life situation, it can be postulated that the mechanism recorded here is likely to optimise absorption and minimise escape of bile acids into the large bowel.
A further interesting observation was that, although inhibiting motility, infusion of GCDC evoked prolonged, high amplitude, isolated contractions in the ileum of some of the subjects. In two subjects (experiments 7-12) the contractions were rapidly propagated distally along varying lengths of bowel. To our knowledge there are no reports of such waves in the ileum of healthy humans during the fed state and their occurrence after GCDC needs further study. Prolonged contractions propagated along the terminal ileum and sometimes crossing the ileocaecal sphincter have been reported in man' and the dog"' during the fasted pattern of motility. In the dog they have been shown to last longer than a single slow wave, to propel fluid and to be evoked by local stimuli such as distention, volatile fatty acids and chenodeoxycholic acid.2' The present experiments do not indicate whether the prolonged propagated contractions observed were triggered by distention of the ileal segment occurring during GCDC infusion, or by GCDC itself. Furthermore, it is unlikely that the occurrence of these waves in the presence of GCDC makes a major contribution to ileal transit as they were recorded in less than half of the experiments and were propagated only on a few occasions. 
